Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.

Authors

Bernhard Mlecnik
Toshihiko Torigoe
Gabriela Bindea
Boryana Popivanova
Mingli Xu
Tomonobu Fujita
Shoichi Hazama
Nobuaki Suzuki
Hiroaki Nagano
Kiyotaka Okuno
Yoshihiko Hirohashi
Tomohisa Furuhata
Ichiro Takemasa
Prabhudas Patel
Hemangini Vora
Birva Shah
Jayendrakumar B Patel
Kruti N Rajvik
Shashank J Pandya
Shilin N Shukla
Yili Wang
Guanjun Zhang
Takayuki Yoshino
Hiroya Taniguchi
Carlo Bifulco, Department of Pathology, Providence Portland Medical Center, Portland, OR 97213, USAFollow
Alessandro Lugli
Jiun-Kae Jack Lee
Inti Zlobec
Tilman T Rau
Martin D Berger
Iris D Nagtegaal
Elisa Vink-Börger
Arndt Hartmann
Carol I Geppert
Julie Kolwelter
Susanne Merkel
Robert Grützmann
Marc Van den Eynde
Anne Jouret-Mourin
Alex Kartheuser
Daniel Léonard
Christophe Remue
Julia Wang
Prashant Bavi
Michael H A Roehrl
Pamela S Ohashi
Linh T Nguyen
SeongJun Han
Heather L MacGregor
Sara Hafezi-Bakhtiari
Bradly G Wouters
Giuseppe V Masucci
Emilia Andersson
Eva Zavadova
Michal Vocka
Jan Spacek
Lubos Petruzelka
Bohuslav Konopasek
Pavel Dundr
Helena Skalova
Kristyna Nemejcova
Gerardo Botti
Fabiana Tatangelo
Paolo Delrio
Gennaro Ciliberto
Michele Maio
Luigi Laghi
Fabio Grizzi
Florence Marliot
Tessa Fredriksen
Bénédicte Buttard
Lucie Lafontaine
Pauline Maby
Amine Majdi
Assia Hijazi
Carine El Sissy
Amos Kirilovsky
Anne Berger
Christine Lagorce
Christopher Paustian
Carmen Ballesteros-Merino
Jeroen Dijkstra
Carlijn Van de Water
Shannon van Lent-van Vliet
Nikki Knijn
Ana-Maria Mușină
Dragos-Viorel Scripcariu
Francesco M Marincola
Paolo A Ascierto
Bernard A Fox, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213, USAFollow
Franck Pagès
Yutaka Kawakami
Jérôme Galon

Document Type

Article

Publication Date

9-6-2022

Publication Title

Cancers (Basel)

Keywords

oregon; portland; ppmc; chiles; Asian; Immunoscore; MSI; T cell; classification; colon cancer; immune response; prognostic markers; risk stratification; tumor microenvironment

Abstract

BACKGROUND: In this study, we evaluated the prognostic value of Immunoscore in patients with stage I-III colon cancer (CC) in the Asian population. These patients were originally included in an international study led by the Society for Immunotherapy of Cancer (SITC) on 2681 patients with AJCC/UICC-TNM stages I-III CC.

METHODS: CD3+ and cytotoxic CD8+ T-lymphocyte densities were quantified in the tumor and invasive margin by digital pathology. The association of Immunoscore with prognosis was evaluated for time to recurrence (TTR), disease-free survival (DFS), and overall survival (OS).

RESULTS: Immunoscore stratified Asian patients (n = 423) into different risk categories and was not impacted by age. Recurrence-free rates at 3 years were 78.5%, 85.2%, and 98.3% for a Low, Intermediate, and High Immunoscore, respectively (HR[Low-vs-High] = 7.26 (95% CI 1.75-30.19);

CONCLUSION: A High Immunoscore is significantly associated with the prolonged survival of CC patients within the Asian population.

Clinical Institute

Digestive Health

Clinical Institute

Cancer

Department

Oncology

Department

Gastroenterology

Department

Earle A. Chiles Research Institute

Share

COinS